AzTrials
AzTrials

Brain Injuries, TraumaticNCT05767502

Assignment of the Verbal Component Score and Addition of Pupil Reaction to the Glasgow Coma Scale

An observational study of Brain Injuries, Traumatic, run by Uludag University at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In this study, it is aimed to determine the prognostic value of GCS-P and the GCS-P score, which is formed by assigning a verbal score, in patients with traumatic brain injury, where all parameters can be evaluated. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Brain Injuries, Traumatic
What is being tested?
GCS-Pupil score
How many people
199 participants
Where
1 siteTurkey (Türkiye)
Study dates
20 Feb 2023to 1 Jun 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: When α: 0.05 β: 0.20 and the acceptable difference between models were selected as 10% using the G-Power program, the number of patients to be included in the study was determined as 199.

Who may be able to join

  • Admitted to hospital due to traumatic brain injury,
  • 18 years and older,
  • who were alive at the time of admission,
  • Patients whose GCS and pupil reactivity can be evaluated completely.

Who cannot join

  • Younger than 18,
  • Not alive at the time of admission,
  • Patients whose GCS score and pupil reactivity are not correctly evaluated (facial trauma, past eye diseases or eye defects, etc.).

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site, 1 recruiting
  • Bursa City Hospital

    Bursa, 16000

    BURSA CITY HOSPITAL ethics committee, ethics, 02249750000 ext. 1150, bursasehir@saglik.gov.tr

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Investigation of the Effect of Assigning Verbal Component Score to Glasgow Coma Scale in Patients With Traumatic Brain Injury and Adding Pupil Reaction to Determining Mortality/Morbidity in Patients

In this study, it is aimed to determine the prognostic value of GCS-P and the GCS-P score, which is formed by assigning a verbal score, in patients with traumatic brain injury, where all parameters can be evaluated. In the model to be created, a new total score will be obtained with Motor score + Eye Response + assigned verbal Score-Pupil score and this score will be compared with GCS and GCS-Pupil score.

Being tested
GCS-Pupil score
Keywords
GCS, GCS-Pupil score, Brain trauma, Consciousness
Medical subject headings
Brain Injuries, Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GCS-Pupil scoreDiagnostic test

    Also called GCS+attributed verbal score- Pupil score

    GCS+attributed verbal score- Step 1 to obtain pupillary score:

    • Patients with a motor (M) and eye-opening response (E) total score between 2 and 6 are assigned a verbal score of +1
    • Patients with an M+E score of 7 are assigned a verbal score of +2
    • Patients with an M+E score of 8-9 are assigned a verbal score of +4
    • Patients with an M+E score of 10 are assigned a verbal score of +5

    GCS+attributed verbal score- Step 2 to obtain the pupillary score:

    The total score is obtained by subtracting the pupil score from the score obtained in the 1st step. Pupil score is scored as follows;

    • 0 points if both pupils react to light,
    • 1 point if a pupil does not react to light and has anisocoria,
    • 2 points if both pupils do not react to light

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. MORTALITY

    Death of the patient while in the hospital

    Measured: From admission to discharge, an average of 1 weeks

  2. MORBIDTIY

    Patients with a Glasgow Outcome score of 2 and 3 (Each patient can get 1-5 points from the Glasgow Outcome score. A low score indicates a negative result.

    Measured: From admission to discharge, an average of 1 weeks

Secondary outcomes (2)
  1. MORTALITY

    Death within 3 months after hospital discharge

    Measured: 3 months after hospital discharge

  2. MORBIDITY

    A Glaskow Coma Outcome Score of 2 and 3 at the end of 3 months after discharge from the hospital. (Each patient can get 1-5 points from the Glasgow Outcome score. A low score indicates a negative result)

    Measured: 3 months after hospital discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Mar 2023
  2. Study start20 Feb 2023
  3. Primary completion1 Mar 2024 (estimated)
  4. Study completion1 Jun 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
199 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05767502
Sponsor's protocol ID
2019-KAEK-140
Status last verified
Mar 2023
First submitted
28 Feb 2023
Last updated
14 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Sharing of study data is not allowed in our country.

Questions about this trial

What is this clinical trial studying?

An observational study of Brain Injuries, Traumatic, run by Uludag University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

MORTALITY (time frame: From admission to discharge, an average of 1 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in